The effect of acute exercise on lymphocyte subsets, natural killer cells, proliferative responses, and cytokines in HIV-seropositive persons

J Acquir Immune Defic Syndr (1988). 1994 Nov;7(11):1122-33.

Abstract

Eight healthy men infected with human immunodeficiency virus, type 1 (HIV) and eight HIV seronegative age- and sex-matched controls exercised on a bicycle ergometer (75% of VO2max, 1 h). The percentages of CD4+, CD4+45RA+, and CD4+45RO+ cells did not change, whereas the absolute number of CD4+ cells increased twofold during exercise and fell below prevalues 2 h after. The neutrophil count increase was more pronounced after exercise in the controls compared with in HIV-seropositive subjects. The percent CD16+ cells, and the natural killer (NK) and lymphokine activated killer (LAK) cell activity increased during exercise, but this increase was significantly less pronounced in the HIV-seropositive group. The results suggest that in response to physical stress, HIV-seropositive subjects have an impaired ability to mobilize neutrophils, NK and LAK cells to the blood. Furthermore, because the total number of CD4+ cells, but not the percentage of CD4+ cells, changed in response to exercise, this study further strengthens the idea that the percentage of CD4+ cells is preferable to the number of CD4+ cells in monitoring patients seropositive for HIV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • CD4 Lymphocyte Count
  • Cytokines / biosynthesis
  • HIV Seropositivity / complications
  • HIV Seropositivity / immunology*
  • Hemoglobins / analysis
  • Humans
  • Interleukin-2 / biosynthesis
  • Killer Cells, Lymphokine-Activated / immunology
  • Killer Cells, Natural / immunology
  • Leukocyte Count
  • Lymphocyte Activation
  • Lymphocyte Subsets / immunology
  • Male
  • Neutrophils / immunology
  • Physical Exertion / physiology*
  • Platelet Count
  • Stress, Physiological / complications
  • Stress, Physiological / immunology*

Substances

  • Cytokines
  • Hemoglobins
  • Interleukin-2